PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,932 | -12.9% | 74,794 | 0.0% | 0.07% | +1.5% |
| Q2 2023 | $341,061 | -13.1% | 74,794 | 0.0% | 0.07% | -10.5% |
| Q1 2023 | $392,668 | +7.0% | 74,794 | 0.0% | 0.08% | +2.7% |
| Q4 2022 | $366,842 | -36.2% | 74,794 | -16.2% | 0.07% | -43.9% |
| Q3 2022 | $575,000 | +1.6% | 89,211 | 0.0% | 0.13% | +15.8% |
| Q2 2022 | $566,000 | +4.8% | 89,211 | +13.9% | 0.11% | +39.0% |
| Q1 2022 | $540,000 | +8.4% | 78,306 | +10.3% | 0.08% | +3.8% |
| Q4 2021 | $498,000 | – | 71,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |